Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The CDC has recognized that familial lipid disorder is a huge health problem and has classified it as a "Tier 1" disease, meaning it has huge health implications with already existing, highly effective therapies. In other words a "winnable" battle.
The good news is that familial lipid disorder is often treatable. With early diagnosis in addition to a proper diet and medication regimen, those with f are able to live longer, healthier lives.
Several new drugs to treat familial lipid disorder patients have recently been approved.
It’s crucial for families that have been tragically affected by the heart attack of a young relative to be aware of familial lipid disorders and be screened for it by their physician.
Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.
Closed trials are not currently enrolling, but may open in the future.